CoChat

Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations

Open access
Scherer, Dominique, Nagore, Eduardo, Bermejo, Justo Lorenzo, Figl, Adina, Botella‐Estrada, Rafael, Thirumaran, Ranjit Kumar, Angelini, Sabrina, Hemminki, Kari, Schadendorf, Dirk, Kumar, Rajiv · 2009 · International Journal of Cancer
Cited by 69

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Variation within the melanocortin receptor 1 (MC1R) gene, that influences phenotypic traits and susceptibility to melanoma, is abundant across the populations. We assessed and compared the risk of melanoma in 2 European populations, German and Spanish, by genotyping MC1R variants through direct DNA sequencing from 1,185 melanoma cases and 1,582 controls. The presence of any variant in both populations was associated with a significantly increased risk of melanoma (odds ratio OR = 1.67, 95% confidence interval CI 1.40–1.99). The population attributable fractions (PAF) associated with the MC1R variants in both populations was over 25%. However, the results showed a statistically significant (p < 0.0001) higher frequency of MC1R variants in the German (70%) than in the Spanish population (60%). The red‐hair colour (RHC) variants, though associated with increased risk in both populations, were more common in the German than in the Spanish population (p < 0.0001). Interestingly, non‐RHC variants increased the disease risk in the Spanish (OR = 1.60, 95% CI 1.20–2.14) but not in the German population (OR = 1.07, 95% CI 0.80–1.44). Although RHC variants explained a major proportion of the observed PAF in the German population, in the Spanish population the major contributor to the PAF was the non‐RHC V60L variant. We also observed reduced historic linkage disequilibrium between the variants V92M and T314T in the gene in German melanoma cases. In conclusion, our data underscored the unambiguous importance of the MC1R variants towards the population burden of melanoma. However, the variants that are associated with the disease differ between the investigated populations. © 2009 UICC

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.24548

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 69

Metadata

Authors
Scherer, D., Nagore, E., Bermejo, J. L., Figl, A., Botella‐Estrada, R., Thirumaran, R. K., Angelini, S., Hemminki, K., Schadendorf, D., & Kumar, R.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2009-07-07
Volume
125
Issue
8
Pages
1868-1875
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2105712032
Cited by
69
References
12
FWCI
3.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations. https://app.cochat.ai/papers/10.1002/ijc.24548
The paper
Scherer, D., Nagore, E., Bermejo, J. L., Figl, A., Botella‐Estrada, R., Thirumaran, R. K., Angelini, S., Hemminki, K., Schadendorf, D., & Kumar, R. (2009). Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations. International Journal of Cancer. https://doi.org/10.1002/ijc.24548

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.